Skip to content

Influence of intradialytic aerobic exercise intensity on efficacy of solute removal from small to large molecular weight substances during hemodialysis in maintenance hemodialysis patient: open label controlled trial.

Influence of intradialytic aerobic exercise intensity on efficacy of solute removal from small to large molecular weight substances during hemodialysis in maintenance hemodialysis patient: open label controlled trial. - Influence of intradialytic aerobic exercise intensity on solute molecular substances removal during hemodialysis in maintenance hemodialysis patient.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038629
Enrollment
20
Registered
2019-11-22
Start date
2016-09-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease (hemodialysis)

Interventions

Exercise interventions1: Sixty minutes low-intensity intradialytic aerobic exercise in supine position. Exercise interventions2: Sixty minutes medium-intensity intradialytic aerobic exercise in supine

Sponsors

Kisen hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Stable medical condition 2.Stable dialysis hemodynamics 3.Walking independence 4.More than half years after introduction of dialysis 5.Meeting the dialysis conditions of this study: online hemodiafiltration, pre-dilution, 4hours dialysis time, blood flow 250mL/min, total dialysate flow rate 650mL/min, 40L replacement fluid volume, uniform water removal rate, dialysate calcium concentration 2.75mEq/L, polysulfone membrane.

Exclusion criteria

Exclusion criteria: 1.Cardiopulmonary exercise test cannot be performed because it is not possible to ride the sitting position ergometer 2.Untreated heart disease 3.Chronic obstructive pulmonary disease 4.Cerebral infarction sequelae 5.Disagreement with the study participation

Design outcomes

Primary

MeasureTime frame
Removal amount of urea nitrogen, phosphate and potassium

Secondary

MeasureTime frame
Removal amount of beta2-microglobulin, alpha1-microglobulin and albumin, and circulating blood volume change

Countries

Japan

Contacts

Public ContactNaoto Usui

Kisen hospital Department of rehabilitation

usui@kisen.or.jp03-3600-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026